1. Home
  2. ASRV vs ACRV Comparison

ASRV vs ACRV Comparison

Compare ASRV & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AmeriServ Financial Inc.

ASRV

AmeriServ Financial Inc.

HOLD

Current Price

$3.79

Market Cap

54.2M

Sector

Finance

ML Signal

HOLD

Logo Acrivon Therapeutics Inc.

ACRV

Acrivon Therapeutics Inc.

HOLD

Current Price

$1.53

Market Cap

47.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASRV
ACRV
Founded
1983
2018
Country
United States
United States
Employees
N/A
78
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.2M
47.6M
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
ASRV
ACRV
Price
$3.79
$1.53
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$13.00
AVG Volume (30 Days)
19.1K
729.1K
Earning Date
04-20-2026
04-20-2026
Dividend Yield
3.19%
N/A
EPS Growth
N/A
13.14
EPS
0.25
N/A
Revenue
$15,621,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$805.34
P/E Ratio
$15.00
N/A
Revenue Growth
7.78
N/A
52 Week Low
$2.03
$1.05
52 Week High
$3.93
$5.75

Technical Indicators

Market Signals
Indicator
ASRV
ACRV
Relative Strength Index (RSI) 60.45 41.92
Support Level $3.01 $1.51
Resistance Level $3.91 $2.47
Average True Range (ATR) 0.14 0.12
MACD -0.00 0.03
Stochastic Oscillator 73.58 17.17

Price Performance

Historical Comparison
ASRV
ACRV

About ASRV AmeriServ Financial Inc.

AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.

About ACRV Acrivon Therapeutics Inc.

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.

Share on Social Networks: